# Histological Validation of dGEMRIC Indices as a Quantitative Biomarker for Cartilage Damage in the Hip Joint

> **NCT06185036** · — · UNKNOWN · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 25 (estimated)

## Conditions studied

- Cartilage Damage
- Osteoarthritis, Hip

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06185036
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-01
- **Primary completion:** 2025-03-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2024-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06185036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06185036, "Histological Validation of dGEMRIC Indices as a Quantitative Biomarker for Cartilage Damage in the Hip Joint". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06185036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*